Name | 1174664-88-0 |
---|
Description | VER-00158411 is a checkpoint kinase 1 (CHK1) and CHK2 inhibitor with IC50 values of 4.4 nM and 4.5 nM, respectively[1]. |
---|---|
Related Catalog | |
Target |
Chk1:4.4 nM (IC50) Chk2:4.5 nM (IC50) |
In Vitro | Cellular sensing of DNA damage, along with concomitant cell cycle arrest, is mediated by a great many proteins and enzymes. One focus of pharmaceutical development has been the inhibition of DNA damage signaling, and checkpoint kinases (CHKs). There have been a number of clinical trial of checkpoint kinase inhibits alone or as a combination therapy for example, as a means to sensitize proliferating tumor cells to chemotherapies that damage DNA. The development of checkpoint kinase inhibitors the treatment of cancer was a major objective in drug discovery[1]. |
References |
[1]. Ann Gee Lisa OOI, et al. Combination therapy. 26 July 2018. WO2018136010A1 |
No Any Chemical & Physical Properties |